---
title: "Sellas Life Sciences 集團第一季度虧損收窄"
type: "News"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/286156649.md"
description: "2026 年 5 月 12 日下午 4:44（東部夏令時間）——SELLAS Life Sciences Group（SLS）在週二晚間報告了第一季度每股攤薄虧損 0.05 美元，較去年同期的 0.07 美元虧損有所收窄。根據 FactSet 的調查，兩位分析師預計虧損為 0.06 美元。第一季度末現金及現金等價物為 1.071 億美元，而第四季度末為 7180 萬美元。該公司股票在盤後交易中上漲超過 12%。MT Newswires 不提供投資建議。未經授權的複製嚴格禁止"
datetime: "2026-05-12T20:44:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286156649.md)
  - [en](https://longbridge.com/en/news/286156649.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286156649.md)
---

# Sellas Life Sciences 集團第一季度虧損收窄

04:44 PM EDT, 05/12/2026 (MT Newswires) -- SELLAS Life Sciences Group ( SLS ) reported a Q1 loss late Tuesday of $0.05 per diluted share, narrowing from a loss of $0.07 a year earlier.

Two analysts polled by FactSet expected a loss of $0.06.

Cash and cash equivalents were $107.1 million at the end of Q1, compared with $71.8 million at the end of Q4.

Shares of the company rose more than 12% in after-hours activity.

MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.

### 相關股票

- [SLS.US](https://longbridge.com/zh-HK/quote/SLS.US.md)
- [FDS.US](https://longbridge.com/zh-HK/quote/FDS.US.md)

## 相關資訊與研究

- [隨着白血病研發管線的推進，Sellas Life Sciences 即將迎來關鍵試驗結果](https://longbridge.com/zh-HK/news/286279161.md)
- [Dagco Inc. 購買了 577,540 股 Sellas Life Sciences 的股票，股票代碼為 SLS](https://longbridge.com/zh-HK/news/280121150.md)
- [從豪華新格局中讀到滿滿誠意 LEXUS 新世代旗艦房車 ALL NEW ES](https://longbridge.com/zh-HK/news/286496781.md)
- [VerifyMe 第一季度收入因失去合作伙伴而下滑](https://longbridge.com/zh-HK/news/286562849.md)
- [在 GPGI 出現季度淨虧損的劇烈波動後，評估其估值](https://longbridge.com/zh-HK/news/287251190.md)